• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

色素沉着过度的管理:现有治疗方法和新兴疗法。

Management of hyperpigmentation: Current treatments and emerging therapies.

机构信息

Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKMs NMIMS, Mumbai, India.

出版信息

Pigment Cell Melanoma Res. 2021 Nov;34(6):1000-1014. doi: 10.1111/pcmr.12986. Epub 2021 Jun 3.

DOI:10.1111/pcmr.12986
PMID:33998768
Abstract

Hyperpigmentation of the skin refers to a dermatological condition which alters the color of the skin, making it discolored or darkened. The treatments for hyperpigmentation disorders often take very long to show results and have poor patient compliance. The first-line treatment for hyperpigmentation involves topical formulations of conventional agents such as hydroquinone, kojic acid, and glycolic acid followed by oral formulations of therapeutic agents such as tranexamic acid, melatonin, and cysteamine hydrochloride. The second-line approaches include chemical peels and laser therapy given under the observation of expert professionals. However, these therapies pose certain limitations and adverse effects such as erythema, skin peeling, and drying and require long treatment duration to show visible effects. These shortcomings of the conventional treatments provided scope for further research on newer alternatives for managing hyperpigmentation. Some of these therapies include novel formulations such as solid lipid nanocarriers, liposomes, phytochemicals, platelet-rich plasma, microneedling. This review focuses on elaborating on several hyperpigmentation disorders and their mechanisms, the current, novel and emerging treatment options for management of hyperpigmentation.

摘要

皮肤色素沉着是一种皮肤疾病,会改变皮肤颜色,使皮肤变色或变暗。治疗色素沉着障碍的方法往往需要很长时间才能见效,而且患者的依从性也很差。治疗色素沉着的一线治疗方法包括外用常规药物制剂,如氢醌、曲酸和乙醇酸,然后再口服治疗药物制剂,如氨甲环酸、褪黑素和半胱胺盐酸盐。二线方法包括在专业人员的观察下进行化学换肤和激光治疗。然而,这些疗法存在一定的局限性和不良反应,如红斑、皮肤剥落、干燥,需要长时间的治疗才能看到明显的效果。这些传统治疗方法的缺点为进一步研究治疗色素沉着的新方法提供了空间。其中一些治疗方法包括新型制剂,如固体脂质纳米载体、脂质体、植物化学物质、富血小板血浆、微针。本综述重点阐述了几种色素沉着障碍及其机制,以及目前、新型和新兴的色素沉着管理治疗选择。

相似文献

1
Management of hyperpigmentation: Current treatments and emerging therapies.色素沉着过度的管理:现有治疗方法和新兴疗法。
Pigment Cell Melanoma Res. 2021 Nov;34(6):1000-1014. doi: 10.1111/pcmr.12986. Epub 2021 Jun 3.
2
4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.4-正丁基间苯二酚,一种高效的酪氨酸酶抑制剂,用于局部治疗色素沉着过度。
J Eur Acad Dermatol Venereol. 2013 Jan;27 Suppl 1:19-23. doi: 10.1111/jdv.12051.
3
A review of therapies for hyperpigmentation modulating the synthesis of eumelanin to pheomelanin.综述了调节真黑素和褐黑素合成的色素沉着治疗方法。
Arch Dermatol Res. 2024 Oct 9;316(9):668. doi: 10.1007/s00403-024-03411-4.
4
Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid.使用含有对苯二酚和乙醇酸的凝胶中的曲酸治疗黄褐斑。
Dermatol Surg. 1999 Apr;25(4):282-4. doi: 10.1046/j.1524-4725.1999.08236.x.
5
An emerging technology in lipid research for targeting hydrophilic drugs to the skin in the treatment of hyperpigmentation disorders: kojic acid-solid lipid nanoparticles.脂质研究中的一项新兴技术,用于将亲水性药物靶向皮肤以治疗色素沉着异常:曲酸固体脂质纳米粒。
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):841-853. doi: 10.1080/21691401.2020.1770271.
6
Prophylaxis of Post-Inflammatory Hyperpigmentation From Energy-Based Device Treatments: A Review.基于能量设备治疗后炎症后色素沉着的预防:综述
J Cutan Med Surg. 2021 Jan-Feb;25(1):77-86. doi: 10.1177/1203475420957633. Epub 2020 Sep 15.
7
Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone.壬二酸与乙醇酸联合治疗深肤色患者面部色素沉着:与氢醌的临床比较
Clin Ther. 1998 Sep-Oct;20(5):960-70. doi: 10.1016/s0149-2918(98)80077-5.
8
Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma.乙醇酸焕肤联合局部用药方案治疗黄褐斑的疗效
J Drugs Dermatol. 2013 Oct;12(10):1149-53.
9
A case report on the use of topical cysteamine 5% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids).一则关于使用 5%巯基乙酸乳膏治疗三联乳膏(对苯二酚、外用皮质类固醇和维 A 酸)治疗抵抗的难治性炎症后色素沉着过度(PIH)的病例报告。
J Cosmet Dermatol. 2021 Jan;20(1):204-206. doi: 10.1111/jocd.13755. Epub 2020 Oct 31.
10
Chemical and instrumental approaches to treat hyperpigmentation.治疗色素沉着过度的化学和仪器方法。
Pigment Cell Res. 2003 Apr;16(2):101-10. doi: 10.1034/j.1600-0749.2003.00029.x.

引用本文的文献

1
Axillary Hyperpigmentation Treatment: A Systematic Review of the Literature.腋窝色素沉着治疗:文献系统评价
J Cosmet Dermatol. 2025 Aug;24(8):e70418. doi: 10.1111/jocd.70418.
2
Clinical Efficacy of Microplasma Radiofrequency in Treating Post-Traumatic Pigmentary Deposition: A VISIA Quantitative Analysis.微等离子体射频治疗创伤后色素沉着的临床疗效:VISIA定量分析
Ther Clin Risk Manag. 2025 Apr 28;21:575-582. doi: 10.2147/TCRM.S508522. eCollection 2025.
3
Multimodality Management of Skin Hyperpigmentation.皮肤色素沉着过度的多模式管理
Aesthetic Plast Surg. 2025 Jul;49(13):3776-3784. doi: 10.1007/s00266-025-04866-0. Epub 2025 Apr 29.
4
Unveiling kratom's dark side: Case report implicating the botanical ingredient as a culprit in recalcitrant photo-exposed hyperpigmentation.揭开 kratom 的阴暗面:病例报告表明这种植物成分是顽固性光暴露性色素沉着的罪魁祸首。
JAAD Case Rep. 2025 Mar 10;59:101-104. doi: 10.1016/j.jdcr.2025.02.017. eCollection 2025 May.
5
In Vitro and In Vivo Assessment of an Innovative Peeling System with Azelaic and Tranexamic Acids for Targeted Hyperpigmentation Reduction.一种含壬二酸和氨甲环酸的创新焕肤系统用于针对性减少色素沉着的体外和体内评估
Dermatol Ther (Heidelb). 2025 May;15(5):1209-1225. doi: 10.1007/s13555-025-01399-x. Epub 2025 Apr 20.
6
QbD-Based Development of Fluocinolone Nanocomposite Transdermal Gel: Optimization, Characterization, and Enhanced Anti-hyperpigmentation Efficacy Assessment.基于质量源于设计的氟轻松纳米复合透皮凝胶的开发:优化、表征及增强的抗色素沉着功效评估
AAPS PharmSciTech. 2025 Apr 2;26(4):100. doi: 10.1208/s12249-025-03094-8.
7
Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation: insights from transcriptomic and proteomic analysis.丙泊酚通过促进MAPK11-PML磷酸化降低术后胶质瘤复发:转录组学和蛋白质组学分析的见解
J Neurooncol. 2025 Apr;172(2):361-376. doi: 10.1007/s11060-024-04906-w. Epub 2025 Feb 28.
8
Insights on the Anti-Inflammatory and Anti-Melanogenic Effects of 2'-Hydroxy-2,6'-dimethoxychalcone in RAW 264.7 and B16F10 Cells.2'-羟基-2,6'-二甲氧基查尔酮对RAW 264.7和B16F10细胞抗炎及抗黑色素生成作用的研究见解
Curr Issues Mol Biol. 2025 Jan 29;47(2):85. doi: 10.3390/cimb47020085.
9
Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α-Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots.一种含有对苯三酚葡萄糖苷和α-熊果苷的外用制剂联合防晒霜使用的疗效和安全性:一项针对患有面部黄褐斑或黑斑的印度女性的非对照、前瞻性干预研究。
J Cosmet Dermatol. 2025 Feb;24(2):e70017. doi: 10.1111/jocd.70017.
10
Efficacy of formulations for treating hyperpigmentation: a systematic review and meta-analysis.治疗色素沉着制剂的疗效:一项系统评价和荟萃分析。
Arch Dermatol Res. 2025 Feb 8;317(1):379. doi: 10.1007/s00403-025-03872-1.